Working… Menu

Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C (Fibrosar)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00265642
Recruitment Status : Completed
First Posted : December 15, 2005
Last Update Posted : February 7, 2014
Information provided by (Responsible Party):
ANRS, Emerging Infectious Diseases

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2013
Actual Study Completion Date : November 2013